3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Gynecologic
2
Gastrointestinal
2
Thoracic
1
Other solid neoplasm
1
Genitourinary
1
Endocrine
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
545
Lung Neoplasms
240
Small Cell Lung Carcinoma
106
Mesothelioma, Malignant
57
Adenocarcinoma of Lung
41
Mesothelioma
35
Neoplasms
27
Neoplasm Metastasis
25
Colorectal Neoplasms
22
Carcinoma
17
Squamous Cell Carcinoma of Head and Neck
15
Ovarian Neoplasms
15
Adenocarcinoma, Bronchiolo-Alveolar
14
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Stomach Neoplasms
12
Pancreatic Neoplasms
12
Non-Squamous Non-Small Cell Lung Cancer
12
Head and Neck Neoplasms
12
Pleural Effusion, Malignant
8
Melanoma
8
Breast Neoplasms
8
Sarcoma
7
Extensive Stage Small Cell Lung Cancer
7
Triple Negative Breast Neoplasms
6
Thymoma
6
Solitary Fibrous Tumor, Pleural
6
NSCLC
6
Endometrial Neoplasms
6
Drug-Related Side Effects and Adverse Reactions
6
Colonic Neoplasms
6
Interventions
sodium thiosulfate
1
X-Rays
1
Specimen Handling
1
Platinum
1
Magnetic Resonance Spectroscopy
1
LY2940680
1
Immunologic Techniques
1
Hyperthermic Intraperitoneal Chemotherapy
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Cisplatin
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled